• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LRP1 是 tau 摄取和扩散的主要调节因子。

LRP1 is a master regulator of tau uptake and spread.

机构信息

Neuroscience Research Institute, Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, CA, USA.

Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.

出版信息

Nature. 2020 Apr;580(7803):381-385. doi: 10.1038/s41586-020-2156-5. Epub 2020 Apr 1.

DOI:10.1038/s41586-020-2156-5
PMID:32296178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7687380/
Abstract

The spread of protein aggregates during disease progression is a common theme underlying many neurodegenerative diseases. The microtubule-associated protein tau has a central role in the pathogenesis of several forms of dementia known as tauopathies-including Alzheimer's disease, frontotemporal dementia and chronic traumatic encephalopathy. Progression of these diseases is characterized by the sequential spread and deposition of protein aggregates in a predictable pattern that correlates with clinical severity. This observation and complementary experimental studies have suggested that tau can spread in a prion-like manner, by passing to naive cells in which it templates misfolding and aggregation. However, although the propagation of tau has been extensively studied, the underlying cellular mechanisms remain poorly understood. Here we show that the low-density lipoprotein receptor-related protein 1 (LRP1) controls the endocytosis of tau and its subsequent spread. Knockdown of LRP1 significantly reduced tau uptake in H4 neuroglioma cells and in induced pluripotent stem cell-derived neurons. The interaction between tau and LRP1 is mediated by lysine residues in the microtubule-binding repeat region of tau. Furthermore, downregulation of LRP1 in an in vivo mouse model of tau spread was found to effectively reduce the propagation of tau between neurons. Our results identify LRP1 as a key regulator of tau spread in the brain, and therefore a potential target for the treatment of diseases that involve tau spread and aggregation.

摘要

在疾病进展过程中蛋白质聚集的扩散是许多神经退行性疾病的一个共同主题。微管相关蛋白 tau 在几种称为 tau 病的痴呆症的发病机制中起着核心作用,包括阿尔茨海默病、额颞叶痴呆和慢性创伤性脑病。这些疾病的进展特征是蛋白质聚集物的顺序扩散和沉积,具有可预测的模式,与临床严重程度相关。这一观察结果和补充性的实验研究表明,tau 可以通过传递到幼稚细胞中,以类似于朊病毒的方式进行传播,在幼稚细胞中,tau 模板错误折叠和聚集。然而,尽管 tau 的传播已经得到了广泛的研究,但潜在的细胞机制仍知之甚少。在这里,我们表明低密度脂蛋白受体相关蛋白 1 (LRP1) 控制 tau 的内吞作用及其随后的扩散。LRP1 的敲低显著降低了 H4 神经胶质瘤细胞和诱导多能干细胞衍生神经元中 tau 的摄取。tau 与 LRP1 之间的相互作用是由 tau 的微管结合重复区中的赖氨酸残基介导的。此外,在 tau 扩散的体内小鼠模型中下调 LRP1 被发现可有效减少神经元之间 tau 的传播。我们的研究结果确定了 LRP1 是大脑中 tau 扩散的关键调节剂,因此是治疗涉及 tau 扩散和聚集的疾病的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b69/7687380/799593402b10/nihms-1568257-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b69/7687380/54c00f3118fe/nihms-1568257-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b69/7687380/62f9514363fc/nihms-1568257-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b69/7687380/8fe25237bb76/nihms-1568257-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b69/7687380/2069b8726b0b/nihms-1568257-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b69/7687380/b2ae5c37baf8/nihms-1568257-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b69/7687380/4408ba5e837f/nihms-1568257-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b69/7687380/799593402b10/nihms-1568257-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b69/7687380/54c00f3118fe/nihms-1568257-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b69/7687380/62f9514363fc/nihms-1568257-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b69/7687380/8fe25237bb76/nihms-1568257-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b69/7687380/2069b8726b0b/nihms-1568257-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b69/7687380/b2ae5c37baf8/nihms-1568257-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b69/7687380/4408ba5e837f/nihms-1568257-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b69/7687380/799593402b10/nihms-1568257-f0004.jpg

相似文献

1
LRP1 is a master regulator of tau uptake and spread.LRP1 是 tau 摄取和扩散的主要调节因子。
Nature. 2020 Apr;580(7803):381-385. doi: 10.1038/s41586-020-2156-5. Epub 2020 Apr 1.
2
LRP1 is a neuronal receptor for α-synuclein uptake and spread.LRP1 是α-突触核蛋白摄取和扩散的神经元受体。
Mol Neurodegener. 2022 Sep 2;17(1):57. doi: 10.1186/s13024-022-00560-w.
3
Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism.LRP1 调节 tau 内化、降解和种子形成,揭示了 tau 代谢的多种途径。
J Biol Chem. 2021 Jan-Jun;296:100715. doi: 10.1016/j.jbc.2021.100715. Epub 2021 Apr 28.
4
Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.在患者来源的 iPSC 神经元中持续监测 Tau 诱导的神经毒性。
J Neurosci. 2021 May 12;41(19):4335-4348. doi: 10.1523/JNEUROSCI.2590-20.2021. Epub 2021 Apr 23.
5
Heparan Sulfate Proteoglycans (HSPGs) Serve as the Mediator Between Monomeric Tau and Its Subsequent Intracellular ERK1/2 Pathway Activation.硫酸乙酰肝素蛋白聚糖 (HSPGs) 作为单体 Tau 与其随后的细胞内 ERK1/2 通路激活之间的中介物。
J Mol Neurosci. 2022 Apr;72(4):772-791. doi: 10.1007/s12031-021-01943-2. Epub 2022 Jan 18.
6
Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake.硫酸乙酰肝素蛋白聚糖和低密度脂蛋白受体相关蛋白 1 构成了神经元淀粉样β摄取的主要途径。
J Neurosci. 2011 Feb 2;31(5):1644-51. doi: 10.1523/JNEUROSCI.5491-10.2011.
7
The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein.低密度脂蛋白受体相关蛋白1(LRP1)介导细胞朊蛋白的内吞作用。
Biochem J. 2007 Feb 15;402(1):17-23. doi: 10.1042/BJ20061736.
8
GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.在向中枢神经系统注射阿尔茨海默病脑源性病理性tau蛋白或合成突变型人tau蛋白原纤维后,绿色荧光蛋白标记的突变型人tau转基因小鼠出现tau蛋白病。
J Neurosci. 2017 Nov 22;37(47):11485-11494. doi: 10.1523/JNEUROSCI.2393-17.2017. Epub 2017 Oct 6.
9
Trans-cellular propagation of Tau aggregation by fibrillar species.纤维状物质介导 Tau 聚集物的细胞间传播。
J Biol Chem. 2012 Jun 1;287(23):19440-51. doi: 10.1074/jbc.M112.346072. Epub 2012 Mar 29.
10
Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.tau 病理传播:实验和人脑研究中的假说、发现和尚未解决的问题。
Acta Neuropathol. 2016 Jan;131(1):27-48. doi: 10.1007/s00401-015-1507-z. Epub 2015 Nov 17.

引用本文的文献

1
Exploring LRP-1 in the liver-brain axis: implications for Alzheimer's disease.探索肝脏-大脑轴中的低密度脂蛋白受体相关蛋白1:对阿尔茨海默病的影响
Mol Biol Rep. 2025 Sep 8;52(1):873. doi: 10.1007/s11033-025-10980-8.
2
Spatiotemporal Dynamics of Central Nervous System Diseases: Advancing Translational Neuropathology via Single-Cell and Spatial Multiomics.中枢神经系统疾病的时空动态:通过单细胞和空间多组学推进转化神经病理学
MedComm (2020). 2025 Aug 19;6(9):e70328. doi: 10.1002/mco2.70328. eCollection 2025 Sep.
3
Sleep reduces CSF concentrations of beta-amyloid and tau: a randomized crossover study in healthy adults.

本文引用的文献

1
Dissection of receptor folding and ligand-binding property with functional minireceptors of LDL receptor-related protein.利用低密度脂蛋白受体相关蛋白的功能性微型受体剖析受体折叠与配体结合特性
J Cell Sci. 2001 Mar;114(Pt 5):899-908. doi: 10.1242/jcs.114.5.899.
睡眠可降低脑脊液中β-淀粉样蛋白和tau蛋白的浓度:一项针对健康成年人的随机交叉研究。
Fluids Barriers CNS. 2025 Aug 19;22(1):84. doi: 10.1186/s12987-025-00698-x.
4
Endothelial delivery of simvastatin by LRP1-targeted nanoparticles ameliorates pathogenesis of alzheimer's disease in a mouse model.通过靶向低密度脂蛋白受体相关蛋白1(LRP1)的纳米颗粒进行辛伐他汀的内皮递送可改善阿尔茨海默病小鼠模型的发病机制。
Alzheimers Res Ther. 2025 Aug 20;17(1):193. doi: 10.1186/s13195-025-01840-5.
5
Understanding the role of microglia in Alzheimer's disease: insights into mechanisms, acupuncture, and potential therapeutic targets.了解小胶质细胞在阿尔茨海默病中的作用:对机制、针灸及潜在治疗靶点的见解
J Tradit Chin Med. 2025 Aug;45(4):922-936. doi: 10.19852/j.cnki.jtcm.20250327.002.
6
Potential link of high fat diet and mRNA expression of Alzheimer's disease-related genes in the enteric mucosa of a rat model of Alzheimer's disease.高脂饮食与阿尔茨海默病大鼠模型肠黏膜中阿尔茨海默病相关基因mRNA表达的潜在联系
J Alzheimers Dis Rep. 2025 Aug 12;9:25424823251358414. doi: 10.1177/25424823251358414. eCollection 2025 Jan-Dec.
7
Tau uptake by human neurons depends on receptor LRP1 and kinase LRRK2.人类神经元对Tau的摄取取决于受体低密度脂蛋白受体相关蛋白1(LRP1)和激酶富含亮氨酸重复激酶2(LRRK2)。
EMBO J. 2025 Aug 11. doi: 10.1038/s44318-025-00514-0.
8
A manifesto for Alzheimer's disease drug discovery in the era of disease-modifying therapies.疾病修饰疗法时代阿尔茨海默病药物研发宣言。
Mol Neurodegener. 2025 Aug 6;20(1):88. doi: 10.1186/s13024-025-00872-7.
9
Tau endo-lysosomal processing in human iPSC-derived microglia is impacted by tau aggregation state, but not by microglial activation status.人诱导多能干细胞衍生的小胶质细胞中tau蛋白的内溶酶体加工过程受tau蛋白聚集状态的影响,但不受小胶质细胞激活状态的影响。
bioRxiv. 2025 Jun 25:2025.06.23.661190. doi: 10.1101/2025.06.23.661190.
10
Proteoglycans are protagonists in autophagy, lymphangiogenesis, and neurodegenerative diseases.蛋白聚糖在自噬、淋巴管生成和神经退行性疾病中起主要作用。
Trends Cell Biol. 2025 Jul 10. doi: 10.1016/j.tcb.2025.06.002.